|
|
|
Evolus Inc (NASDAQ: EOLS) |
|
|
|
| |
Evolus Inc Outlook |
On January 21 2025 the Evolus Inc provided following guidance
nnEvolus Inc. Reports Preliminary Unaudited Financial Results for Q4 and Full-Year 2024, Setting New Revenue Milestonesnn
Evolus Inc. has released its preliminary financial estimates for the fourth quarter and the entirety of the fiscal year ending December 31, 2024. The disclosed figures demonstrate an impressive performance that not only meets but reaches the upper limits of the company's previously set guidance.
The company's announcement highlights that their net revenue results for both the fourth quarter and the full year are anticipated to be record-breaking. Unfortunately, specific numerical data regarding net revenue or detailed financial guidance figures have not been disclosed at this time.
Based in Newport Beach, California, Evolus, Inc. (NASDAQ: EOLS) is recognized as a leader in the global performance beauty industry, with an emphasis on enhancing its aesthetic product offerings. The preliminary unaudited results cited in this announcement are derived from the latest available information collected by the management team. It is important to note that these figures could be subject to adjustments until the formal audit of the company's financial performance for 2024 is finalized.
This promising financial outlook reflects the company's strategic initiatives and dedication to growth within the beauty sector, positioning Evolus for potential continued success in the coming periods.,
|
On March 7 2024 the Evolus Inc provided following guidance
Evolus Inc, a performance beauty company known for its customer-centric approach and breakthrough products, has reported record-breaking financial results for the fourth quarter and full year of 2023. The company, listed on the NASDAQ under the ticker symbol EOLS, saw significant growth in market share throughout the year, solidifying its position as the fastest-growing toxin in the U.S. for the third consecutive year.
In addition to its success in the U.S. market, Evolus also expanded its portfolio globally by introducing an innovative late-stage product. This expansion has allowed the company to reach new markets and further establish itself as a leader in the beauty industry.
Looking ahead to 2024, Evolus has reaffirmed its guidance and is optimistic about its future prospects. The company is committed to delivering groundbreaking products and maintaining its customer-centric approach to drive continued growth and success. With a strong foundation established in 2023, Evolus is poised for further growth and innovation in the years to come.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
